middle.news
CMS Boosts Telix’s Gozellix with Key US Reimbursement Win
9:45am on Tuesday 23rd of September, 2025 AEST
•
Healthcare
Read Story
CMS Boosts Telix’s Gozellix with Key US Reimbursement Win
9:45am on Tuesday 23rd of September, 2025 AEST
Key Points
CMS grants Transitional Pass-Through payment status for Gozellix
Separate reimbursement under Hospital Outpatient Prospective Payment System from October 2025
Permanent HCPCS Level II code A9616 assigned for Gozellix
Gozellix offers longer shelf life and flexible production methods
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Telix Pharmaceuticals (ASX:TLX)
OPEN ARTICLE